# Efficacy of a 14-Day Bismuth-Containing Quadruple Therapy Guided by Drug Susceptibility Testing in Patients with Extremely Refractory Helicobacter Pylori Infection: an Exploratory Study

> **NCT06731023** · — · NOT_YET_RECRUITING · sponsor: **Xiuli Zuo** · enrollment: 30 (estimated)

## Conditions studied

- HELICOBACTER PYLORI INFECTIONS

## Interventions

- **DRUG:** Bismuth
- **DRUG:** Vonoprazan
- **DRUG:** Amoxicillin
- **DRUG:** Rifabutin
- **DRUG:** Metronidazole
- **DRUG:** Other antibiotics

## Key facts

- **NCT ID:** NCT06731023
- **Lead sponsor:** Xiuli Zuo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06731023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06731023, "Efficacy of a 14-Day Bismuth-Containing Quadruple Therapy Guided by Drug Susceptibility Testing in Patients with Extremely Refractory Helicobacter Pylori Infection: an Exploratory Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06731023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*